Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2024 05:00 ET | Source: EsoCap AG

EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis

Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharmacology & TherapeuticsESO-101 leverages EsoCap’s unique drug delivery technology to...
September 05, 2023 03:30 ET | Source: EsoCap AG

EsoCap completes patient recruitment in ACESO Phase II trial in eosinophilic esophagitis

EsoCap's novel targeted delivery platform is designed to increase mucosal contact time and drug deposition in the esophagus ESO-101, EsoCap's lead product candidate, consists of a capsule with a...
October 26, 2021 03:00 ET | Source: EsoCap AG

EsoCap announces first patient enrolled in Phase II eosinophilic esophagitis trial

Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101ESO-101, EsoCap’s lead product candidate, consists of a capsule with a...
September 09, 2021 03:00 ET | Source: EsoCap AG

EsoCap – unique targeted application platform to treat the upper gastrointestinal tract

EsoCap’s targeted application technology drastically increases mucosal contact time and enables effective local treatment of various esophageal diseases for the first timeProof of principle in human...